Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood

Journal of Cardiovascular Translational Research

Volumn 6, Issue 4, 2013, Pages 588-603

  Gezmish, Oksan ^a   Black, Mary Jane ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cardiomyocytes; Cardiomyopathy; Heart failure; Maternal vitamin D deficiency; Renin angiotensin system; Vitamin D deficiency

Indexed keywords

OXYGENASE; VITAMIN D; VITAMIN D RECEPTOR;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CONGENITAL HEART MALFORMATION; DIETARY INTAKE; DISEASE ASSOCIATION; FETUS HEART; GROWTH RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; HYPERVITAMINOSIS; LACTATION; MATERNAL NUTRITION; NONHUMAN; NUTRITIONAL ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK FACTOR; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGE FACTORS; ANIMALS; CARDIOVASCULAR DISEASES; FEMALE; FETAL HEART; HUMANS; INFANT; INFANT, NEWBORN; LACTATION; MYOCYTES, CARDIAC; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880509150     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9475-y     Document Type: Article

References (212)

1. Abe, E.; Miyaura, C.; Sakagami, H.; Takeda, M.; Konno, K.; Yamazaki, T.; et al. (1981). Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proceedings of the National Academy of Sciences of the United States of America, 78, 4990-4994.
2. Al Kalbani, M.; Elshafie, O.; Rawahi, M.; Al-Mamari, A.; Al-Zakwani, A.; & Woodhouse, N. (2011). Vitamin D status in pregnant Omanis: a disturbingly high proportion of patients with low vitamin D stores. Sultan Qaboos Univ Med J, 11, 52-55.
3. Alagol, F.; Shihadeh, Y.; Boztepe, H.; Tanakol, R.; Yarman, S.; Azizlerli, H.; et al. (2000). Sunlight exposure and vitamin D deficiency in Turkish women. Journal of Endocrinological Investigation, 23, 173-177.
4. Andiran, N.; Yordam, N.; & Ozon, A. (2002). Risk factors for vitamin D deficiency in breast-fed newborns and their mothers. Nutrition, 18, 47-50.
5. Atli, T.; Gullu, S.; Uysal, A. R.; & Erdogan, G. (2005). The prevalence of vitamin D deficiency and effects of ultraviolet light on vitamin D levels in elderly Turkish population. Archives of Gerontology and Geriatrics, 40, 53-60. doi: 10.1016/j.archger.2004.05.006.
6. Baker, A. M.; Haeri, S.; Camargo, C. A.; Jr.; Espinola, J. A.; & Stuebe, A. M. (2010). A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. The Journal of Clinical Endocrinology and Metabolism, 95, 5105-5109. doi: 10.1210/jc.2010-0996.
7. Banerjee, P.; & Chatterjee, M. (2003). Antiproliferative role of vitamin D and its analogs - a brief overview. Molecular and Cellular Biochemistry, 253, 247-254.
8. Barker, D. J. (2006). Birth weight and hypertension. Hypertension, 48, 357-358. doi: 10.1161/01.HYP.0000236552.04251.42.
9. Barker, D. J. (1995). Fetal origins of coronary heart disease. BMJ, 311, 171-174.
10. Barker, D. J.; Gluckman, P. D.; Godfrey, K. M.; Harding, J. E.; Owens, J. A.; & Robinson, J. S. (1993). Fetal nutrition and cardiovascular disease in adult life. The Lancet, 341, 938-941.
11. Bassir, M.; Laborie, S.; Lapillonne, A.; Claris, O.; Chappuis, M. C.; & Salle, B. L. (2001). Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatrica, 90, 577-579.
12. Bikle, D. (2009). Nonclassic actions of vitamin D. The Journal of Clinical Endocrinology and Metabolism, 94, 26-34. doi: 10.1210/jc.2008-1454.
13. Bikle, D. D. (2010). Vitamin D: an ancient hormone. Experimental Dermatology, 20, 7-13.
14. Black, M. J.; Bertram, J. F.; Campbell, J. H.; & Campbell, G. R. (1995). Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats. Journal of Hypertension, 13, 683-692.
15. Black, M. J.; Kanellakis, P.; & Bobik, A. (1997). Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats. Journal of Hypertension, 15, 945-954.
16. Bodnar, L. M.; Catov, J. M.; Roberts, J. M.; & Simhan, H. N. (2007). Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates. The Journal of Nutrition, 137, 2437-2442.
17. Bodnar, L. M.; Catov, J. M.; Simhan, H. N.; Holick, M. F.; Powers, R. W.; & Roberts, J. M. (2007). Maternal vitamin D deficiency increases the risk of preeclampsia. The Journal of Clinical Endocrinology and Metabolism, 92, 3517-3522. doi: 10.1210/jc.2007-0718.
18. Bodnar, L. M.; Catov, J. M.; Zmuda, J. M.; Cooper, M. E.; Parrott, M. S.; Roberts, J. M.; et al. (2010). Maternal serum 25-hydroxyvitamin D concentrations are associated with small-for-gestational age births in white women. The Journal of Nutrition, 140, 999-1006. doi: 10.3945/jn.109.119636.
19. Bodnar, L. M.; Simhan, H. N.; Powers, R. W.; Frank, M. P.; Cooperstein, E.; & Roberts, J. M. (2007). High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. The Journal of Nutrition, 137, 447-452.
20. Bodyak, N.; Ayus, J. C.; Achinger, S.; Shivalingappa, V.; Ke, Q.; Chen, Y. S.; et al. (2007). Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proceedings of the National Academy of Sciences of the United States of America, 104, 16810-16815. doi: 10.1073/pnas.0611202104.
21. Bouillon, R. (2009). Vitamin D as potential baseline therapy for blood pressure control. American Journal of Hypertension, 22, 816. doi: 10.1038/ajh.2009.105.
22. Bowyer, L.; Catling-Paull, C.; Diamond, T.; Homer, C.; Davis, G.; & Craig, M. E. (2009). Vitamin D, PTH and calcium levels in pregnant women and their neonates. Clinical Endocrinology, 70, 372-377. doi: 10.1111/j.1365-2265. 2008.03316.x.
23. Brock, K.; Wilkinson, M.; Cook, R.; Lee, S.; & Bermingham, M. (2004). Associations with vitamin D deficiency in "at risk" Australians. The Journal of Steroid Biochemistry and Molecular Biology, 89-90, 581-588. doi: 10.1016/j.jsbmb.2004.03.073S0960076004001281.
24. Brown, J.; Nunez, S.; Russell, M.; & Spurney, C. (2009). Hypocalcemic rickets and dilated cardiomyopathy: case reports and review of literature. Pediatric Cardiology, 30, 818-823. doi: 10.1007/s00246-009-9444-z.
25. Brunvand, L.; Haga, P.; Tangsrud, S. E.; & Haug, E. (1995). Congestive heart failure caused by vitamin D deficiency? Acta Paediatrica, 84, 106-108.
26. Burgess, E. D.; Hawkins, R. G.; & Watanabe, M. (1990). Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. American Journal of Hypertension, 3, 903-905.
27. Burrell, J. H.; Boyn, A. M.; Kumarasamy, V.; Hsieh, A.; Head, S. I.; & Lumbers, E. R. (2003). Growth and maturation of cardiac myocytes in fetal sheep in the second half of gestation. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 274, 952-961. doi: 10.1002/ar.a.10110.
28. Calvo, M. S.; Whiting, S. J.; & Barton, C. N. (2005). Vitamin D intake: a global perspective of current status. The Journal of Nutrition, 135, 310-316.
29. Cannell, J. J.; Hollis, B. W.; Zasloff, M.; & Heaney, R. P. (2008). Diagnosis and treatment of vitamin D deficiency. Expert Opinion on Pharmacotherapy, 9, 107-118. doi: 10.1517/14656566.9.1.107.
30. Carlson, B. M. (2004). Human embryology and developmental biology 3rd ed. Philadelphia: Mosby.
31. Carlton-Conway, D.; Tulloh, R.; Wood, L.; & Kanabar, D. (2004). Vitamin D deficiency and cardiac failure in infancy. Journal of the Royal Society of Medicine, 97, 238-239.
32. Chien, K. R.; Zhu, H.; Knowlton, K. U.; Miller-Hance, W.; van-Bilsen, M.; O'Brien, T. X.; et al. (1993). Transcriptional regulation during cardiac growth and development. Annual Review of Physiology, 55, 77-95. doi: 10.1146/annurev.ph.55.030193.000453.
33. Claycomb, W. C. (1992). Control of cardiac muscle cell division. Trends in Cardiovascular Medicine, 2, 231-236. doi: 10.1016/1050-1738(92)90030-V.
34. Clemens, T. L.; Adams, J. S.; Henderson, S. L.; & Holick, M. F. (1982). Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. The Lancet, 1, 74-76.
35. Clubb, F. J.; Jr.; & Bishop, S. P. (1984). Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy. Laboratory Investigation, 50, 571-577.
36. Colston, K.; Colston, M. J.; & Feldman, D. (1981). 1,25-Dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology, 108, 1083-1086.
37. Colston, K. W.; Pirianov, G.; Bramm, E.; Hamberg, K. J.; & Binderup, L. (2003). Effects of seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors. Breast Cancer Research and Treatment, 80, 303-311. doi: 10.1023/A:1024962316691.
38. Daaboul, J.; Sanderson, S.; Kristensen, K.; & Kitson, H. (1997). Vitamin D deficiency in pregnant and breast-feeding women and their infants. Journal of Perinatology, 17, 10-14.
39. Das, G.; Crocombe, S.; McGrath, M.; Berry, J. L.; & Mughal, M. Z. (2006). Hypovitaminosis D among healthy adolescent girls attending an inner city school. Archives of Disease in Childhood, 91, 569-572. doi: 10.1136/adc.2005.077974.
40. DeLuca, H. F. (2004). Overview of general physiologic features and functions of vitamin D. The American Journal of Clinical Nutrition, 80, 1689S-1696S.
41. DeLuca, H. F. (1988). The vitamin D story: a collaborative effort of basic science and clinical medicine. The FASEB Journal, 2, 224-236.
42. Delvin, E. E.; Glorieux, F. H.; Salle, B. L.; David, L.; & Varenne, J. P. (1982). Control of vitamin D metabolism in preterm infants: feto-maternal relationships. Archives of Disease in Childhood, 57, 754-757.
43. Dent, C. E.; & Gupta, M. M. (1975). Plasma 25-hydroxyvitamin-D-levels during pregnancy in Caucasians and in vegetarian and non-vegetarian Asians. The Lancet, 2, 1057-1060.
44. Desai, M.; & Hales, C. N. (1997). Role of fetal and infant growth in programming metabolism in later life. Biological Reviews of the Cambridge Philosophical Society, 72, 329-348.
45. Ebeling, P. R. (2011). Routine screening for vitamin D deficiency in early pregnancy: past its due date? The Medical Journal of Australia, 194, 332-333.
46. Ekbote, V. H.; Khadilkar, A. V.; Mughal, M. Z.; Hanumante, N.; Sanwalka, N.; Khadilkar, V. V.; et al. (2010). Sunlight exposure and development of rickets in Indian toddlers. Indian Journal of Pediatrics, 77, 61-65. doi: 10.1007/s12098-009-0263-2.
47. El Abdaimi, K.; Dion, N.; Papavasiliou, V.; Cardinal, P. E.; Binderup, L.; Goltzman, D.; et al. (2000). The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Research, 60, 4412-4418.
48. Eyles, D.; Brown, J.; Mackay-Sim, A.; McGrath, J.; & Feron, F. (2003). Vitamin D3 and brain development. Neuroscience, 118, 641-653.
49. Fleischman, A. R.; Rosen, J. F.; Cole, J.; Smith, C. M.; & Deluca, H. F. (1980). Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. The Journal of Pediatrics, 97, 640-642.
50. Flicker, L.; Mead, K.; MacInnis, R. J.; Nowson, C.; Scherer, S.; Stein, M. S.; et al. (2003). Serum vitamin D and falls in older women in residential care in Australia. Journal of the American Geriatrics Society, 51, 1533-1538.
51. Forman, J. P.; Giovannucci, E.; Holmes, M. D.; Bischoff-Ferrari, H. A.; Tworoger, S. S.; Willett, W. C.; et al. (2007). Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension, 49, 1063-1069. doi: 10.1161/HYPERTENSIONAHA.107.087288.
52. Gannage-Yared, M. H.; Chemali, R.; Yaacoub, N.; & Halaby, G. (2000). Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. Journal of Bone and Mineral Research, 15, 1856-1862. doi: 10.1359/jbmr.2000.15. 9.1856.
53. Gertner, J. M.; Glassman, M. S.; Coustan, D. R.; & Goodman, D. B. (1980). Fetomaternal vitamin D relationships at term. The Journal of Pediatrics, 97, 637-640.
54. Gezmish, O.; Tare, M.; Parkington, H. C.; Morley, R.; Porrello, E. R.; Bubb, K. J.; et al. (2010). Maternal vitamin D deficiency leads to cardiac hypertrophy in rat offspring. Reproductive Sciences, 17, 168-176. doi: 10.1177/1933719109349536.
55. Gilbert S. F. (2006). Developmental biology (8th ed). Sunderland (MA): Sinauer Associates.
56. Gordon, C. M.; DePeter, K. C.; Feldman, H. A.; Grace, E.; & Emans, S. J. (2004). Prevalence of vitamin D deficiency among healthy adolescents. Archives of Pediatrics & Adolescent Medicine, 158, 531-537. doi: 10.1001/archpedi.158.6.531158/6/531.
57. Goss, R. J. (1966). Hypertrophy versus hyperplasia. Science, 153, 1615-1620.
58. Grant, W. B.; & Holick, M. F. (2005). Benefits and requirements of vitamin D for optimal health: a review. Alternative Medicine Review, 10, 94-111.
59. Greer, F. R. (2008). 25-Hydroxyvitamin D: functional outcomes in infants and young children. The American Journal of Clinical Nutrition, 88, 529S-533S.
60. Grover, S. R.; & Morley, R. (2001). Vitamin D deficiency in veiled or dark-skinned pregnant women. The Medical Journal of Australia, 175, 251-252.
61. Gurlek, A.; & Kumar, R. (2001). Regulation of osteoblast growth by interactions between transforming growth factor-beta and 1alpha,25- dihydroxyvitamin D3. Critical Reviews in Eukaryotic Gene Expression, 11, 299-317.
62. Gurlek, A.; Pittelkow, M. R.; & Kumar, R. (2002). Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation. Endocrine Reviews, 23, 763-786.
63. Haddad, J. G.; Matsuoka, L. Y.; Hollis, B. W.; Hu, Y. Z.; & Wortsman, J. (1993). Human plasma transport of vitamin D after its endogenous synthesis. The Journal of Clinical Investigation, 91, 2552-2555. doi: 10.1172/JCI116492.
64. Halicioglu, O.; Aksit, S.; Koc, F.; Akman, S. A.; Albudak, E.; Yaprak, I.; et al. (2012). Vitamin D deficiency in pregnant women and their neonates in spring time in western Turkey. Paediatric and Perinatal Epidemiology, 26, 53-60. doi: 10.1111/j.1365-3016.2011.01238.x.
65. Halloran, B. P.; Barthell, E. N.; & DeLuca, H. F. (1979). Vitamin D metabolism during pregnancy and lactation in the rat. Proceedings of the National Academy of Sciences of the United States of America, 76, 5549-5553.
66. Heaney, R. P. (2004). Functional indices of vitamin D status and ramifications of vitamin D deficiency. The American Journal of Clinical Nutrition, 80, 1706S-1709S.
67. Heaney, R. P. (2008). Vitamin D: criteria for safety and efficacy. Nutrition Reviews, 66, S178-S181. doi: 10.1111/j.1753-4887.2008.00102.x.
68. Heaney, R. P.; Davies, K. M.; Chen, T. C.; Holick, M. F.; & Barger-Lux, M. J. (2003). Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. The American Journal of Clinical Nutrition, 77, 204-210.
69. Holick, M. F. (2003). Evolution and function of vitamin D. Recent Results in Cancer Research, 164, 3-28.
70. Holick, M. F. (2006). High prevalence of vitamin D inadequacy and implications for health. Mayo Clinic Proceedings, 81, 353-373.
71. Holick, M. F. (1994). McCollum Award Lecture, 1994: vitamin D - new horizons for the 21st century. The American Journal of Clinical Nutrition, 60, 619-630.
72. Holick, M. F. (2006). Resurrection of vitamin D deficiency and rickets. The Journal of Clinical Investigation, 116, 2062-2072. doi: 10.1172/JCI29449.
73. Holick, M. F. (2001). Sunlight "D"ilemma: risk of skin cancer or bone disease and muscle weakness. The Lancet, 357, 4-6. doi: 10.1016/S0140-6736(00)03560-1.
74. Holick, M. F. (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. The American Journal of Clinical Nutrition, 80, 1678S-1688S.
75. Holick, M. F. (1990). The use and interpretation of assays for vitamin D and its metabolites. The Journal of Nutrition, 120(11), 1464-1469.
76. Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357, 266-281. doi: 10.1056/NEJMra070553.
77. Holick, M. F. (2011). Vitamin D: a d-lightful solution for health. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, 59, 872-880. doi: 10.231/JIM.0b013e318214ea2d.
78. Holick, M. F. (2002). Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Current Opinion in Endocrinology, Diabetes, and Obesity, 9, 87-98.
79. Holick, M. F.; Biancuzzo, R. M.; Chen, T. C.; Klein, E. K.; Young, A.; Bibuld, D.; et al. (2008). Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. The Journal of Clinical Endocrinology and Metabolism, 93, 677-681. doi: 10.1210/jc.2007-2308.
80. Holick, M. F.; Frommer, J. E.; McNeill, S. C.; Richtand, N. M.; Henley, J. W.; & Potts, J. T.; Jr. (1977). Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochemical and Biophysical Research Communications, 76, 107-114.
81. Holick, M. F.; MacLaughlin, J. A.; & Doppelt, S. H. (1981). Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science, 211, 590-593.
82. Holick, M. F.; Matsuoka, L. Y.; & Wortsman, J. (1989). Age, vitamin D, and solar ultraviolet. The Lancet, 2, 1104-1105.
83. Hollis, B. W. (2005). Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. The Journal of Nutrition, 135, 317-322.
84. Hollis, B. W. (1984). Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. Journal of Steroid Biochemistry, 21, 81-86.
85. Hollis, B. W.; Roos, B. A.; Draper, H. H.; & Lambert, P. W. (1981). Vitamin D and its metabolites in human and bovine milk. The Journal of Nutrition, 111, 1240-1248.
86. Hollis, B. W.; & Wagner, C. L. (2004). Assessment of dietary vitamin D requirements during pregnancy and lactation. The American Journal of Clinical Nutrition, 79, 717-726.
87. Hollis, B. W.; & Wagner, C. L. (2004). Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. The American Journal of Clinical Nutrition, 80, 1752S-1758S.
88. Holmes, V. A.; Barnes, M. S.; Alexander, H. D.; McFaul, P.; & Wallace, J. M. (2009). Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. The British Journal of Nutrition, 102, 876-881. doi: 10.1017/S0007114509297236.
89. Husain, K.; Ferder, L.; Mizobuchi, M.; Finch, J.; & Slatopolsky, E. (2009). Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. American Journal of Nephrology, 29, 465-472. doi: 10.1159/000178251.
90. Institute of Medicine. (2010). In Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNB (Ed.), Dietary reference intakes of calcium and vitamin D. Washington DC: National Academy Press.
91. Iqbal, S. J. (1994). Vitamin D metabolism and the clinical aspects of measuring metabolites. Annals of Clinical Biochemistry, 31(2), 109-124.
92. Isaia, G.; Giorgino, R.; Rini, G. B.; Bevilacqua, M.; Maugeri, D.; & Adami, S. (2003). Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporosis International, 14, 577-582. doi: 10.1007/s00198-003-1390-7.
93. Johnson, D. D.; Wagner, C. L.; Hulsey, T. C.; McNeil, R. B.; Ebeling, M.; & Hollis, B. W. (2010). Vitamin D deficiency and insufficiency is common during pregnancy. American Journal of Perinatology. doi: 10.1055/s-0030-1262505.
94. Jones, G. (2008). Pharmacokinetics of vitamin D toxicity. The American Journal of Clinical Nutrition, 88, 582S-586S.
95. Jones, G.; Strugnell, S. A.; & DeLuca, H. F. (1998). Current understanding of the molecular actions of vitamin D. Physiological Reviews, 78, 1193-1231.
96. Judd, S. E.; Nanes, M. S.; Ziegler, T. R.; Wilson, P. W.; & Tangpricha, V. (2008). Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. The American Journal of Clinical Nutrition, 87, 136-141.
97. Judkins, A.; & Eagleton, C. (2006). Vitamin D deficiency in pregnant New Zealand women. The New Zealand Medical Journal, 119, U2144.
98. Karim, S. A.; Nusrat, U.; & Aziz, S. (2011). Vitamin D deficiency in pregnant women and their newborns as seen at a tertiary-care center in Karachi, Pakistan. International Journal of Gynaecology and Obstetrics, 112, 59-62. doi: 10.1016/j.ijgo.2010.07.034.
99. Kimura, Y.; Kawamura, M.; Owada, M.; Oshima, T.; Murooka, M.; Fujiwara, T.; et al. (1999). Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Internal Medicine, 38, 31-35.
100. Kinyamu, H. K.; Gallagher, J. C.; Rafferty, K. A.; & Balhorn, K. E. (1998). Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites. The American Journal of Clinical Nutrition, 67, 342-348.
101. Kitano, Y.; Ikeda, N.; & Okano, M. (1991). Suppression of proliferation of human epidermal keratinocytes by 1,25-dihydroxyvitamin D3. Analysis of its effect on psoriatic lesion and of its mechanism using human keratinocytes in culture. European Journal of Clinical Investigation, 21, 53-58.
102. Kosecik, M.; & Ertas, T. (2007). Dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. Pediatrics International, 49, 397-399. doi: 10.1111/j.1442-200X.2007.02367.x.
103. Koutkia, P.; Chen, T. C.; & Holick, M. F. (2001). Vitamin D intoxication associated with an over-the-counter supplement. The New England Journal of Medicine, 345, 66-67. doi: 10.1056/NEJM200107053450114.
104. Kreiter, S. R.; Schwartz, R. P.; Kirkman, H. N.; Jr.; Charlton, P. A.; Calikoglu, A. S.; & Davenport, M. L. (2000). Nutritional rickets in African American breast-fed infants. The Journal of Pediatrics, 137, 153-157. doi: 10.1067/mpd.2000.109009.
105. Kwong, W. Y.; Wild, A. E.; Roberts, P.; Willis, A. C.; & Fleming, T. P. (2000). Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development, 127, 4195-4202.
106. Larsen, W. J. (2001). Human embryology (3rd ed.). New York: Churchill Livingston.
107. Lee, J. H.; Gadi, R.; Spertus, J. A.; Tang, F.; & O'Keefe, J. H. (2011). Prevalence of vitamin d deficiency in patients with acute myocardial infarction. The American Journal of Cardiology, 107, 1636-1638. doi: 10.1016/j.amjcard.2011.01.048.
108. Lee, M. A.; Bohm, M.; Paul, M.; & Ganten, D. (1993). Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation, 87, IV7-13.
109. Leffelaar, E. R.; Vrijkotte, T. G.; & van Eijsden, M. (2010). Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multi-ethnic Amsterdam Born Children and their Development cohort. The British Journal of Nutrition, 104, 108-117. doi: 10.1017/S000711451000022X.
110. Lehmann, B.; & Meurer, M. (2010). Vitamin D metabolism. Dermatologic Therapy, 23, 2-12. doi: 10.1111/j.1529-8019.2009.01286.x.
111. Lewis, S.; Lucas, R. M.; Halliday, J.; & Ponsonby, A. L. (2011). Vitamin D deficiency and pregnancy: from preconception to birth. Molecular Nutrition & Food Research, 54, 1092-1102. doi: 10.1002/mnfr.201000044.
112. Li, F.; Wang, X.; Capasso, J. M.; & Gerdes, A. M. (1996). Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. Journal of Molecular and Cellular Cardiology, 28, 1737-1746. doi: 10.1006/jmcc.1996.0163.
113. Li, Y. C.; Kong, J.; Wei, M.; Chen, Z. F.; Liu, S. Q.; & Cao, L. P. (2002). 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. The Journal of Clinical Investigation, 110, 229-238. doi: 10.1172/JCI15219.
114. Li, Y. C.; Qiao, G.; Uskokovic, M.; Xiang, W.; Zheng, W.; & Kong, J. (2004). Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. The Journal of Steroid Biochemistry and Molecular Biology, 89-90, 387-392. doi: 10.1016/j.jsbmb.2004.03.004S0960076004000494.
115. Lointier, P.; Wargovich, M. J.; Saez, S.; Levin, B.; Wildrick, D. M.; & Boman, B. M. (1987). The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Research, 7, 817-821.
116. MacLaughlin, J.; & Holick, M. F. (1985). Aging decreases the capacity of human skin to produce vitamin D3. The Journal of Clinical Investigation, 76, 1536-1538. doi: 10.1172/JCI112134.
117. MacLaughlin, J. A.; Anderson, R. R.; & Holick, M. F. (1982). Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science, 216, 1001-1003.
118. MacLaughlin, J. A.; Gange, W.; Taylor, D.; Smith, E.; & Holick, M. F. (1985). Cultured psoriatic fibroblasts from involved and uninvolved sites have a partial but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3. Proceedings of the National Academy of Sciences of the United States of America, 82, 5409-5412.
119. Maghbooli, Z.; Hossein-Nezhad, A.; Karimi, F.; Shafaei, A. R.; & Larijani, B. (2008). Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes/Metabolism Research and Reviews, 24, 27-32. doi: 10.1002/dmrr.737.
120. Maiya, S.; Sullivan, I.; Allgrove, J.; Yates, R.; Malone, M.; Brain, C.; et al. (2008). Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart, 94, 581-584. doi: 10.1136/hrt.2007.119792.
121. Maka, N.; Makrakis, J.; Parkington, H. C.; Tare, M.; Morley, R.; & Black, M. J. (2008). Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Pediatric Nephrology, 23, 55-61. doi: 10.1007/s00467-007-0641-9.
122. Mancuso, P.; Rahman, A.; Hershey, S. D.; Dandu, L.; Nibbelink, K. A.; & Simpson, R. U. (2008). 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. Journal of Cardiovascular Pharmacology, 51, 559-564. doi: 10.1097/FJC.0b013e3181761906.
123. Markestad, T.; Aksnes, L.; Ulstein, M.; & Aarskog, D. (1984). 25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy. The American Journal of Clinical Nutrition, 40, 1057-1063.
124. Martins, D.; Wolf, M.; Pan, D.; Zadshir, A.; Tareen, N.; Thadhani, R.; et al. (2007). Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine, 167, 1159-1165. doi: 10.1001/archinte.167.11.1159.
125. Masuda, S.; & Jones, G. (2006). Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Molecular Cancer Therapeutics, 5, 797-808. doi: 10.1158/1535-7163.MCT-05-0539.
126. Matsuoka, L. Y.; Ide, L.; Wortsman, J.; MacLaughlin, J. A.; & Holick, M. F. (1987). Sunscreens suppress cutaneous vitamin D3 synthesis. The Journal of Clinical Endocrinology and Metabolism, 64, 1165-1168.
127. Mattila, P.; Suonpaa, K.; & Piironen, V. (2000). Functional properties of edible mushrooms. Nutrition, 16, 694-696.
128. Mayhew, T. M.; Pharaoh, A.; Austin, A.; & Fagan, D. G. (1997). Stereological estimates of nuclear number in human ventricular cardiomyocytes before and after birth obtained using physical disectors. Journal of Anatomy, 191(Pt 1), 107-115.
129. McGrath, J. J.; Kimlin, M. G.; Saha, S.; Eyles, D. W.; & Parisi, A. V. (2001). Vitamin D insufficiency in south-east Queensland. The Medical Journal of Australia, 174, 150-151.
130. Melamed, M. L.; Muntner, P.; Michos, E. D.; Uribarri, J.; Weber, C.; Sharma, J.; et al. (2008). Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1179-1185. doi: 10.1161/ATVBAHA.108.165886.
131. Mishal, A. A. (2001). Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporosis International, 12, 931-935.
132. Mithal, A.; Wahl, D. A.; Bonjour, J. P.; Burckhardt, P.; Dawson-Hughes, B.; Eisman, J. A.; et al. (2009). Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis International, 20, 1807-1820. doi: 10.1007/s00198-009-0954-6.
133. Morimoto, S.; Onishi, T.; Imanaka, S.; Yukawa, H.; Kozuka, T.; Kitano, Y.; et al. (1986). Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases. Calcified Tissue International, 38, 119-122.
134. Morimoto, S.; Yoshikawa, K.; Kozuka, T.; Kitano, Y.; Imanaka, S.; Fukuo, K.; et al. (1986). Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3 - open-design study. Calcified Tissue International, 39, 209-212.
135. Munns, C.; Zacharin, M. R.; Rodda, C. P.; Batch, J. A.; Morley, R.; Cranswick, N. E.; et al. (2006). Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. The Medical Journal of Australia, 185, 268-272.
136. Nagpal, S.; Na, S.; & Rathnachalam, R. (2005). Noncalcemic actions of vitamin D receptor ligands. Endocrine Reviews, 26, 662-687. doi: 10.1210/er.2004-0002.
137. Nascimento, F. A.; Ceciliano, T. C.; Aguila, M. B.; & Mandarim-de-Lacerda, C. A. (2012). Maternal vitamin D deficiency delays glomerular maturity in F1 and F2 offspring. PloS One, 7, e41740. doi: 10.1371/journal.pone.0041740PONE-D-11-25892.
138. Health, N.; & Council, M. R. (2006). Nutrients reference values for Australia and New Zealand including recommended dietary intakes. Canberra: Australian Government Publishing Services.
139. Nesby-O'Dell, S.; Scanlon, K. S.; Cogswell, M. E.; Gillespie, C.; Hollis, B. W.; Looker, A. C.; et al. (2002). Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. The American Journal of Clinical Nutrition, 76, 187-192.
140. Nibbelink, K. A.; Tishkoff, D. X.; Hershey, S. D.; Rahman, A.; & Simpson, R. U. (2007). 1,25(OH)2-Vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. The Journal of Steroid Biochemistry and Molecular Biology, 103, 533-537. doi: 10.1016/j.jsbmb.2006.12.099.
141. Norman, A. W. (1998). Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. The American Journal of Clinical Nutrition, 67, 1108-1110.
142. Nowson, C. A.; & Margerison, C. (2002). Vitamin D intake and vitamin D status of Australians. The Medical Journal of Australia, 177, 149-152.
143. O'Connell, T. D.; Berry, J. E.; Jarvis, A. K.; Somerman, M. J.; & Simpson, R. U. (1997). 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. The American Journal of Physiology, 272, H1751-1758.
144. O'Connell, T. D.; & Simpson, R. U. (1995). 1,25-Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart. Biochemical and Biophysical Research Communications, 213, 59-65.
145. Olgun, H.; Ceviz, N.; & Ozkan, B. (2003). A case of dilated cardiomyopathy due to nutritional vitamin D deficiency rickets. The Turkish Journal of Pediatrics, 45, 152-154.
146. Ovesen, L.; Andersen, R.; & Jakobsen, J. (2003). Geographical differences in vitamin D status, with particular reference to European countries. The Proceedings of the Nutrition Society, 62, 813-821. doi: 10.1079/PNS2003297S0029665103001071.
147. Ovesen, L.; Brot, C.; & Jakobsen, J. (2003). Food contents and biological activity of 25-hydroxyvitamin D: a vitamin D metabolite to be reckoned with? Annals of Nutrition and Metabolism, 47, 107-113.
148. Park, C. W.; Oh, Y. S.; Shin, Y. S.; Kim, C. M.; Kim, Y. S.; Kim, S. Y.; et al. (1999). Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. American Journal of Kidney Diseases, 33, 73-81.
149. Pasco, J. A.; Henry, M. J.; Nicholson, G. C.; Sanders, K. M.; & Kotowicz, M. A. (2001). Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. The Medical Journal of Australia, 175, 401-405.
150. Pearce, S. H.; & Cheetham, T. D. (2010). Diagnosis and management of vitamin D deficiency. BMJ, 340, b5664.
151. Perampalam, S.; Ganda, K.; Chow, K. A.; Opie, N.; Hickman, P. E.; Shadbolt, B.; et al. (2011). Vitamin D status and its predictive factors in pregnancy in 2 Australian populations. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 51, 353-359. doi: 10.1111/j.1479-828X.2011.01313.x.
152. Peters, B. S.; Fisberg, M.; Wood, R. J.; Martini, L. A.; & dos Santos, L. C. (2009). Prevalence of vitamin D insufficiency in Brazilian adolescents. Annals of Nutrition and Metabolism, 54, 15-21. doi: 10.1159/000199454.
153. Pilz, S.; Dobnig, H.; Fischer, J. E.; Wellnitz, B.; Seelhorst, U.; Boehm, B. O.; et al. (2008). Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke, 39, 2611-2613. doi: 10.1161/STROKEAHA.107. 513655.
154. Pilz, S.; Tomaschitz, A.; Marz, W.; Drechsler, C.; Ritz, E.; Zittermann, A.; et al. (2011). Vitamin D, cardiovascular disease and mortality. Clinical Endocrinology, 75, 575-584. doi: 10.1111/j.1365-2265.2011.04147.x.
155. Poole, K. E.; Loveridge, N.; Barker, P. J.; Halsall, D. J.; Rose, C.; Reeve, J.; et al. (2006). Reduced vitamin D in acute stroke. Stroke, 37, 243-245. doi: 10.1161/01.STR.0000195184.24297.c1.
156. Price, D. I.; Stanford, L. C.; Jr.; Braden, D. S.; Ebeid, M. R.; & Smith, J. C. (2003). Hypocalcemic rickets: an unusual cause of dilated cardiomyopathy. Pediatric Cardiology, 24, 510-512. doi: 10.1007/s00246-002-0251- z.
157. Pugliese, M. T.; Blumberg, D. L.; Hludzinski, J.; & Kay, S. (1998). Nutritional rickets in suburbia. Journal of the American College of Nutrition, 17, 637-641.
158. Ramel, A.; Jonsson, P. V.; Bjornsson, S.; & Thorsdottir, I. (2009). Vitamin D deficiency and nutritional status in elderly hospitalized subjects in Iceland. Public Health Nutrition, 12, 1001-1005. doi: 10.1017/S1368980008004527.
159. Rashid, S. F.; Moore, J. S.; Walker, E.; Driver, P. M.; Engel, J.; Edwards, C. E.; et al. (2001). Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene, 20, 1860-1872. doi: 10.1038/sj.onc.1204269.
160. Ray, D.; Goswami, R.; Gupta, N.; Tomar, N.; Singh, N.; & Sreenivas, V. (2009). Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their 25(OH)D and calcium intake rather than vitamin D receptor gene polymorphism. Clinical Endocrinology, 71, 334-340. doi: 10.1111/j.1365-2265.2008.03500.x.
161. Reeve, L. E.; Chesney, R. W.; & DeLuca, H. F. (1982). Vitamin D of human milk: identification of biologically active forms. The American Journal of Clinical Nutrition, 36, 122-126.
162. Resnick, L. M.; Muller, F. B.; & Laragh, J. H. (1986). Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Annals of Internal Medicine, 105, 649-654.
163. Robinson, C. J.; Alanis, M. C.; Wagner, C. L.; Hollis, B. W.; & Johnson, D. D. (2010). Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. American Journal of Obstetrics and Gynecology, 203(366), e361-366. doi: 10.1016/j.ajog.2010.06.036.
164. Rudolph, A. M. (2000). Myocardial growth before and after birth: clinical implications. Acta Paediatrica, 89, 129-133.
165. Sadoshima, J.; & Izumo, S. (1993). Molecular characterization of angiotensin II - induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circulation Research, 73, 413-423.
166. Salle, B. L.; Delvin, E. E.; Lapillonne, A.; Bishop, N. J.; & Glorieux, F. H. (2000). Perinatal metabolism of vitamin D. The American Journal of Clinical Nutrition, 71, 1317S-1324S.
167. Samuel, S.; & Sitrin, M. D. (2008). Vitamin D's role in cell proliferation and differentiation. Nutrition Reviews, 66, S116-124. doi: 10.1111/j.1753-4887.2008.00094.x.
168. Scragg, R.; Jackson, R.; Holdaway, I. M.; Lim, T.; & Beaglehole, R. (1990). Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. International Journal of Epidemiology, 19, 559-563.
169. Scragg, R.; Sowers, M.; & Bell, C. (2007). Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. American Journal of Hypertension, 20, 713-719. doi: 10.1016/j.amjhyper.2007.01.017.
170. Shabahang, M.; Buras, R. R.; Davoodi, F.; Schumaker, L. M.; Nauta, R. J.; Uskokovic, M. R.; et al. (1994). Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Cancer Research, 54, 4057-4064.
171. Simboli-Campbell, M.; Narvaez, C. J.; van Weelden, K.; Tenniswood, M.; & Welsh, J. (1997). Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Research and Treatment, 42, 31-41.
172. Skull, S. A.; Ngeow, J. Y.; Biggs, B. A.; Street, A.; & Ebeling, P. R. (2003). Vitamin D deficiency is common and unrecognized among recently arrived adult immigrants from The Horn of Africa. Internal Medicine Journal, 33, 47-51.
173. Smith, E. L.; Walworth, N. C.; & Holick, M. F. (1986). Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. The Journal of Investigative Dermatology, 86, 709-714.
174. Soheilykhah, S.; Mojibian, M.; Rashidi, M.; Rahimi-Saghand, S.; & Jafari, F. (2010). Maternal vitamin D status in gestational diabetes mellitus. Nutrition in Clinical Practice, 25, 524-527. doi: 10.1177/0884533610379851.
175. Soonpaa, M. H.; Kim, K. K.; Pajak, L.; Franklin, M.; & Field, L. J. (1996). Cardiomyocyte DNA synthesis and binucleation during murine development. The American Journal of Physiology, 271, H2183-2189.
176. Stroud, M. L.; Stilgoe, S.; Stott, V. E.; Alhabian, O.; & Salman, K. (2008). Vitamin D - a review. Australian Family Physician, 37, 1002-1005.
177. Sutton, A. L.; & MacDonald, P. N. (2003). Vitamin D: more than a "bone-a-fide" hormone. Molecular Endocrinology, 17, 777-791. doi: 10.1210/me.2002-0363me.2002-0363.
178. Swain, R.; & Kaplan, B. (1995). Vitamins as therapy in the 1990s. The Journal of the American Board of Family Practice, 8, 206-216.
179. Tanaka, H.; Abe, E.; Miyaura, C.; Kuribayashi, T.; Konno, K.; Nishii, Y.; et al. (1982). 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). The Biochemical Journal, 204, 713-719.
180. Tao, M.; Shao, H.; Gu, J.; & Zhen, Z. (2012). Vitamin D status of pregnant women in Shanghai, China. The Journal of Maternal-Fetal & Neonatal Medicine, 25, 237-239. doi: 10.3109/14767058.2011.569613.
181. Tao, M.; Shao, H.; Gu, J.; & Zhen, Z. (2011). Vitamin D status of pregnant women in Shanghai. China. J Matern Fetal Neonatal Med. doi: 10.3109/14767058.2011.569613.
182. Tare, M.; Emmett, S. J.; Coleman, H. A.; Skordilis, C.; Eyles, D. W.; Morley, R.; et al. (2011). Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. The Journal of Physiology, 589, 4777-4786. doi: 10.1113/jphysiol.2011.214726.
183. Teale, G. R.; & Cunningham, C. E. (2010). Vitamin D deficiency is common among pregnant women in rural Victoria. The Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, 259-261. doi: 10.1111/j.1479-828X. 2010.01147.x.
184. Theobald, H. E. (2007). Eating for pregnancy and breast-feeding. The Journal of Family Health Care, 17, 45-49.
185. Thomas, M. G.; Tebbutt, S.; & Williamson, R. C. (1992). Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut, 33, 1660-1663.
186. Tsang, R.; Zlotkin, S.; Nichols, B.; & Hansen, J. (1997). Nutrition during infancy: principles and practice. Cincinnati: Digital Education.
187. Tsiaras, W. G.; & Weinstock, M. A. (2011). Factors influencing vitamin D status. Acta Dermato-Venereologica, 91, 115-124. doi: 10.2340/00015555-0980.
188. U.S. Department of Agriculture, Agricultural Research Service. (2011). USDA National Nutrient Database for Standard Reference, Release 24. Nutrient Data Laboratory Home Page, http://www.ars.usda.gov/nutrientdata. Accessed 17 Dec 2012.
189. Uysal, S.; Kalayci, A. G.; & Baysal, K. (1999). Cardiac functions in children with vitamin D deficiency rickets. Pediatric Cardiology, 20, 283-286.
190. van der Meer, I. M.; Karamali, N. S.; Boeke, A. J.; Lips, P.; Middelkoop, B. J.; Verhoeven, I.; et al. (2006). High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. The American Journal of Clinical Nutrition, 84, 350-353. quiz 468-359.
191. van der Mei, I. A.; Ponsonby, A. L.; Engelsen, O.; Pasco, J. A.; McGrath, J. J.; Eyles, D. W.; et al. (2007). The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environmental Health Perspectives, 115, 1132-1139. doi: 10.1289/ehp.9937.
192. Vieth, R. (2004). Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. The Journal of Steroid Biochemistry and Molecular Biology, 89-90, 575-579. doi: 10.1016/j.jsbmb.2004.03.038S096007600400086X.
193. Wagner, C. L.; Hulsey, T. C.; Fanning, D.; Ebeling, M.; & Hollis, B. W. (2006). High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeeding Medicine, 1, 59-70. doi: 10.1089/bfm.2006.1.59.
194. Walters, M. R.; Wicker, D. C.; & Riggle, P. C. (1986). 1,25-Dihydroxyvitamin D3 receptors identified in the rat heart. Journal of Molecular and Cellular Cardiology, 18, 67-72.
195. Ward, L. M.; Gaboury, I.; Ladhani, M.; & Zlotkin, S. (2007). Vitamin D-deficiency rickets among children in Canada. CMAJ, 177, 161-166. doi: 10.1503/cmaj.061377.
196. Waterston, D. (1918). The development of the heart in man. Trans Roy Soc Edin, 52, 257-302.
197. Weishaar, R. E.; Kim, S. N.; Saunders, D. E.; & Simpson, R. U. (1990). Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. The American Journal of Physiology, 258, E134-142.
198. Weishaar, R. E.; & Simpson, R. U. (1987). Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. The American Journal of Physiology, 253, E675-683.
199. Weishaar, R. E.; & Simpson, R. U. (1987). Vitamin D3 and cardiovascular function in rats. The Journal of Clinical Investigation, 79, 1706-1712. doi: 10.1172/JCI113010.
200. Weng, F. L.; Shults, J.; Leonard, M. B.; Stallings, V. A.; & Zemel, B. S. (2007). Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. The American Journal of Clinical Nutrition, 86, 150-158.
201. Widdowson, E. M.; & McCance, R. A. (1975). A review: new thoughts on growth. Pediatric Research, 9, 154-156. doi: 10.1203/00006450-197503000-00010.
202. Wootton, A. M. (2005). Improving the measurement of 25-hydroxyvitamin D. Clinical Biochemistry Reviews, 26, 33-36.
203. Wu, G.; Fan, R. S.; Li, W.; Ko, T. C.; & Brattain, M. G. (1997). Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene, 15, 1555-1563. doi: 10.1038/sj.onc.1201329.
204. Xiang, W.; Kong, J.; Chen, S.; Cao, L. P.; Qiao, G.; Zheng, W.; et al. (2005). Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. American Journal of Physiology, Endocrinology and Metabolism, 288, E125-132. doi: 10.1152/ajpendo.00224. 200400224.2004.
205. Zak, R. (1974). Development and proliferative capacity of cardiac muscle cells. Circulation Research, 35(suppl II), 17-26.
206. Zehnder, D.; Bland, R.; Walker, E. A.; Bradwell, A. R.; Howie, A. J.; Hewison, M.; et al. (1999). Expression of 25-hydroxyvitamin D3-1alpha- hydroxylase in the human kidney. Journal of the American Society of Nephrology, 10, 2465-2473.
207. Zerwekh, J. E. (2008). Blood biomarkers of vitamin D status. The American Journal of Clinical Nutrition, 87, 1087S-1091S.
208. Zhao, X. Y.; Peehl, D. M.; Navone, N. M.; & Feldman, D. (2000). 1alpha,25-Dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms. Endocrinology, 141, 2548-2556.
209. Zhou, C.; Lu, F.; Cao, K.; Xu, D.; Goltzman, D.; & Miao, D. (2008). Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney International, 74, 170-179. doi: 10.1038/ki.2008.101.
210. Zittermann, A.; & Gummert, J. F. (2010). Sun, vitamin D, and cardiovascular disease. Journal of Photochemistry and Photobiology. B, 101, 124-129. doi: 10.1016/j.jphotobiol.2010.01.006.
211. Zittermann, A.; Schleithoff, S. S.; & Koerfer, R. (2006). Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Failure Reviews, 11, 25-33. doi: 10.1007/s10741-006-9190-8.
212. Zittermann, A.; Schleithoff, S. S.; Tenderich, G.; Berthold, H. K.; Korfer, R.; & Stehle, P. (2003). Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Journal of the American College of Cardiology, 41, 105-112.